Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir

Background The role of the antiviral therapy in treatment of COVID-19 is still a matter to be investigated. Also efficacy and safety of antiviral regimens were not compared according severity of the disease. In this study the efficacy and safety of hydroxychloroquine plus atazanavir/ritonavir was co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Daru 2020-12, Vol.28 (2), p.625-634
Hauptverfasser:	Rahmani, Hamid, Davoudi-Monfared, Effat, Nourian, Anahid, Nabiee, Morteza, Sadeghi, Setayesh, Khalili, Hossein, Abbasian, Ladan, Ghiasvand, Fereshteh, Seifi, Arash, Hasannezhad, Malihe, Ghaderkhani, Sara, Mohammadi, Mostafa, Yekaninejad, Mir Saeed
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral agents Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Atazanavir Sulfate - administration & dosage Atazanavir Sulfate - adverse effects Biomedical and Life Sciences Biomedicine Care and treatment Comparative analysis COVID-19 COVID-19 - mortality COVID-19 - virology COVID-19 Drug Treatment Drug Therapy, Combination Female Hospital patients Hospitalization - statistics & numerical data Humans Hydroxychloroquine Hydroxychloroquine - administration & dosage Hydroxychloroquine - adverse effects Intensive Care Units - statistics & numerical data Length of Stay Male Medical research Medicinal Chemistry Middle Aged Mortality Patient outcomes Pharmaceutical Sciences/Technology Pharmacology/Toxicology Prospective Studies Research Article Ritonavir - administration & dosage Ritonavir - adverse effects Severity of Illness Index Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!